About this trial
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients.
The main questions it aims to answer are:
\- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works to change LDL and HDL cholesterol level.
Participants will:
* Take propolis or a placebo, 2 times daily with given dose (1 drops/10 kg/times) every day for 2 months * Visit the sub-district health centre once every 2 weeks for checkups * Get their blood checked before and after intervention
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Controlled Diabetes Mellitus type 2 with HbA1c <7.5%
BMI 23-35 kg/m2
On anti-cholesterol therapy
Disqualifiers
Using injection therapy (insulin or GLP-1 RA)
History of bees product allergy
Active smoker
Consuming alcohol
Trial design
Parallel
Treatments tested in this trial
Propolis drops
DrugThe intervention given is propolis drops that are approved by Indonesian Food and Drug Authority
Placebo
Other interventionThe given placebo are look-alike substance with no effect
Treatment groups
Trial outcomes
Primary outcomes
Low Density Lipoprotein
LDL level will be measured twice, before and after intervention
High Density Lipoprotein
HDL will be measured twice, before and after intervention
Sponsors and contacts
Click on the lead sponsor to view all of their trials.